NMN and NR Coverage: How to Use ICHRA, HSA, FSA, and Employer Benefits to Lower Your Cost

Why NMN and NR Have No Standard Insurance Coverage

NMN and NR are sold as dietary supplements, not as FDA-approved pharmaceuticals. The FDA's framework for dietary supplements under DSHEA does not require pre-market efficacy or safety review, which means no drug code (NDC), no formulary slot, and no path to standard medical or pharmacy benefit coverage. A commercial insurer, Medicare, or Medicaid will not process a claim for NMN or NR under any current billing code.

This matters for you practically: no prior authorization process exists to pursue, and no appeal to an insurer's medical necessity department will succeed without a billing code attached to a covered benefit category.

The Regulatory Wrinkle That Adds Complexity

In 2022 the FDA issued a warning letter indicating that NMN may be excluded from the dietary supplement category because it was previously investigated as a drug (FDA warning letter, November 2022). The agency has not finalized that position, and NMN products continue to be sold widely, but the regulatory ambiguity means coverage programs can shift quickly. Check the status of any product before making a large purchase.

How HSA and FSA Accounts Can Reduce Your Out-of-Pocket Cost

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) are the most accessible cost-reduction tool for most women. Both accounts allow tax-free spending on "medical care" as defined by IRS Publication 502, which includes prescription medicines and, under certain conditions, OTC items purchased to treat a specific medical diagnosis.

NMN and NR are not automatically FSA/HSA-eligible as general wellness supplements. The pathway to reimbursement is a Letter of Medical Necessity (LMN).

What a Letter of Medical Necessity Must Say

An LMN is a signed clinician document that connects a specific IRS-recognized diagnosis to the supplement. For NMN or NR to have a reasonable chance of reimbursement, the letter should include:

• Your diagnosed condition (for example, PCOS-related insulin resistance, postmenopausal metabolic dysfunction, or mitochondrial-related fatigue with a documented ICD-10 code)
• A statement that the supplement is recommended to treat or mitigate that specific condition, not for general wellness
• The recommended dose and duration
• Your clinician's NPI number, signature, and date

Even with an LMN, your FSA or HSA administrator makes the final eligibility call. Some third-party FSA administrators (Optum, WageWorks, HealthEquity) have internal policies that automatically decline supplements regardless of an LMN. Call your administrator before submitting.

FSA vs. HSA: Key Differences for Women

| Feature | FSA | HSA | |---|---|---| | Who can have one | Any employer plan | Must be enrolled in HDHP | | 2026 contribution limit | $3,300 (individual) | $4,300 (individual) / $8,550 (family) | | Use-it-or-lose-it | Yes (typically) | No, rolls over indefinitely | | OTC supplement flexibility | Administrator-dependent | Administrator-dependent | | Best life stage fit | Active employment, any age | HDHP holders, good for perimenopause planning |

The HSA rollover feature makes it particularly useful for perimenopausal women who may be building a longer-term supplement or HRT budget. You invest unused HSA dollars, let them grow tax-free, and spend them later on qualified medical expenses including any that become eligible in the future.

ICHRA: What It Is and Whether It Covers NMN or NR

An Individual Coverage Health Reimbursement Arrangement (ICHRA) is an employer-funded account that reimburses employees for individual health insurance premiums and, depending on plan design, for additional qualifying medical expenses. ICHRAs were established by final federal regulations in 2019 and became broadly available January 1, 2020.

The core rule: ICHRA reimbursements must be for expenses that qualify as medical care under IRC Section 213(d), the same standard as HSA/FSA. Dietary supplements for general wellness do not qualify. Supplements recommended to treat a diagnosed condition may qualify, again only with adequate documentation.

How to Find Out If Your ICHRA Covers Supplements

Your employer's ICHRA plan document is the controlling text. Ask your HR department or ICHRA administrator (common platforms in 2026 include PeopleKeep, Take Command Health, and Thatch) for:

1. The Summary Plan Description (SPD)
2. The expense eligibility list, specifically whether IRC 213(d) OTC items are included
3. The substantiation process (receipt only vs. LMN required)

Some ICHRA platforms allow employers to expand the eligible expense list to include a broader set of OTC items. If your employer has opted into expanded OTC coverage, a supplement like NMN may be reimbursable without an LMN. This is the exception, not the rule, but worth checking.

ICHRA and the Life-Stage Context

For perimenopausal and postmenopausal women employed at companies offering ICHRA instead of group insurance, the ICHRA dollars may also be your primary mechanism for covering individual-market insurance premiums. Use ICHRA funds strategically: prioritize premium reimbursement first (the largest and most certain benefit), then explore supplement reimbursement as a secondary ask. A telehealth visit at WomanRx to document a clinical indication for NAD+ support could establish the LMN needed to reveal that secondary reimbursement.

Employer Wellness Stipends: A Simpler Path

Many mid-size and large employers now offer lifestyle spending accounts (LSAs) or wellness stipends alongside or separate from ICHRA and FSA benefits. Unlike HSAs and FSAs, LSAs are funded by the employer and are not governed by IRS medical-expense rules. Employers can define eligible expenses however they choose, including supplements, gym memberships, and wearables.

Here is a practical framework for checking whether your employer's wellness benefit can cover NMN or NR:

Step 1. Pull your total benefits package document. Look for terms like "lifestyle spending account," "wellness reimbursement," "well-being stipend," or "health stipend."

Step 2. Check the eligible expense list. Supplements are covered by some LSAs explicitly. Others list "vitamins and supplements" as excluded.

Step 3. If the list is ambiguous, submit a receipt with a product description and let the platform decide. Many LSA administrators (Forma, Benepass, Compt) process claims quickly and will tell you if a category is ineligible.

Step 4. If supplements are excluded, ask HR whether the plan can be amended. LSA design is employer-driven and can change at open enrollment.

Step 5. If your employer offers a health coaching or concierge medicine benefit, ask whether a clinician within that benefit can write an LMN for your FSA or HSA reimbursement.

LSA dollars are taxable income to you as an employee, unlike HSA or FSA contributions, which are pre-tax. Factor that in when calculating your real savings.

Women-Specific Clinical Context: Why NAD+ Precursors Matter Across Life Stages

Understanding the clinical rationale for NMN or NR is not just academic. It directly affects your ability to get an LMN from a clinician and, by extension, access tax-advantaged reimbursement. A clinician who understands the evidence can link your diagnosis to the supplement more credibly.

Reproductive Years and PCOS

Polycystic ovary syndrome affects approximately 8-13% of women of reproductive age worldwide. Insulin resistance is a core feature. NAD+ is a cofactor for SIRT1, a sirtuin that modulates insulin signaling, and preclinical data suggests NMN supplementation improves insulin sensitivity in metabolically stressed states. Direct randomized trial data in women with PCOS is not yet available as of early 2026. This is an extrapolated rationale, not a proven indication. If your clinician uses PCOS-related insulin resistance as your LMN diagnosis, they should document that the evidence basis is mechanistic and emerging.

Perimenopause and Postmenopause

This is where the strongest human data currently sits. The Yoshino et al. 2021 randomized controlled trial published in Science enrolled 25 postmenopausal women with prediabetes and overweight. Ten weeks of NMN at 250 mg/day increased muscle insulin sensitivity and skeletal muscle NAD+ metabolome compared to placebo, with no serious adverse events. The sample was small and the duration short. Larger confirmatory trials are needed before NMN can be described as an established treatment.

NAD+ tissue levels decline progressively after age 40, with some estimates suggesting a 40-50% reduction in NAD+ between ages 40 and 60. Estrogen loss in menopause may compound this decline because estrogen supports mitochondrial biogenesis pathways that depend on NAD+. The intersection of menopause and NAD+ depletion is an active area of research, and the evidence gap is real: most NAD+ precursor trials have enrolled predominantly male or mixed-sex cohorts without sex-stratified reporting.

Postpartum and Lactation

No human trial has studied NMN or NR in postpartum women. NAD+ metabolism is altered during lactation because niacin equivalents are secreted in breast milk, but whether exogenous NMN supplementation meaningfully affects milk composition or infant NAD+ status is unknown. Given this data vacuum, avoid NMN and NR during lactation until safety data exists.

Pregnancy and Lactation Safety

NMN and NR are not established as safe in human pregnancy or lactation. Do not take them if you are pregnant, planning pregnancy, or breastfeeding.

There is no FDA pregnancy category for dietary supplements. Animal data on NMN in pregnancy is limited to rodent studies showing that NAD+ precursor supplementation may reduce the incidence of certain congenital defects caused by niacin deficiency, as published by Shi et al. In Nature Medicine (2017). This is mechanistically interesting but cannot be translated directly to human supplementation guidance. No human randomized data on NMN or NR in pregnancy exists.

Lactation transfer has not been studied. The molecular weight of NMN (334.2 g/mol) is low enough that transfer into breast milk is plausible, and downstream effects on the nursing infant are unknown.

Practical guidance by life stage:

• Trying to conceive: Discuss with your reproductive endocrinologist or OB-GYN before starting. If used, stop at confirmed pregnancy.
• Pregnant: Do not use NMN or NR. Adequate dietary niacin (the precursor to NAD+) through prenatal vitamins is the evidence-based approach.
• Breastfeeding: Avoid. No safety data.
• Postpartum (not breastfeeding): May resume with clinician guidance once lactation has stopped.

Who This Is Right For and Who Should Pause

Women for Whom This Cost Navigation Is Most Relevant

• Perimenopausal and postmenopausal women (ages 40-65) with a documented metabolic condition such as prediabetes, type 2 diabetes, or metabolic syndrome who have a clinician willing to write an LMN linking NAD+ support to their diagnosis.
• Women with PCOS and confirmed insulin resistance, with the understanding that the trial evidence is early-stage and the LMN rationale is mechanistic.
• Women enrolled in HDHP plans with HSA access who are building a long-term supplement budget.
• Employees at companies with LSA or wellness stipend programs that explicitly allow supplements.

Women Who Should Not Prioritize This Right Now

• Pregnant women. Full stop.
• Women actively trying to conceive without clinician clearance.
• Breastfeeding women.
• Women without a documented clinical indication whose only goal is general "anti-aging." An LMN for general wellness will not survive FSA/HSA administrator review, and the evidence base does not support paying out-of-pocket at high cost for a wellness-only rationale when the data in women remains thin.

How to Get NMN or NR Cheaper: Discount Programs and Buying Strategies

If your employer benefits don't cover NMN or NR and your HSA/FSA administrator denies the claim, these strategies reduce retail cost:

Manufacturer Subscription Programs

Most reputable NMN and NR brands offer auto-ship subscriptions that discount 15-30% off single-purchase price. Examples of brands with active subscription models as of 2026 include Tru Niagen (NR), Elysium Basis (NR), and several NMN-specific brands. Subscription pricing on a 500 mg/day NMN protocol typically lands between $55-$80/month vs. $70-$120/month at single-purchase retail.

Third-Party Discounters

Costco, Amazon Subscribe and Save, and iHerb carry NR and NMN products at 10-20% below manufacturer MSRP. Quality varies. Look for products that have been third-party tested by NSF International, USP, or Informed Sport, because the supplement industry is not required to verify label claims.

Telehealth LMN as an Investment

A single telehealth visit at WomanRx to establish clinical documentation ($75-$150 out of pocket, often HSA/FSA reimbursable as a medical visit) may reveal months of FSA/HSA reimbursement. If you spend $80/month on NMN and your marginal tax rate is 24%, FSA reimbursement saves you roughly $230/year on a $960 annual supplement spend. The math favors the visit.

Dose Optimization to Reduce Cost

The Yoshino et al. Trial used 250 mg/day NMN and showed measurable NAD+ metabolome effects in postmenopausal women. Some consumers take 500-1,000 mg/day based on extrapolation from other trials, but no dose-response study in women has established that higher doses produce proportionally greater benefit. Starting at 250-300 mg/day rather than 500 mg/day cuts cost by 40-50% while remaining within the studied dose range.

What the Evidence Actually Shows (And Where the Gaps Are)

Women have been underrepresented in NAD+ precursor trials, and this is a clinically meaningful gap. Most mechanistic and early-phase human trials enrolled predominantly male participants or did not report results stratified by sex. The Yoshino 2021 trial is a notable exception specifically enrolling postmenopausal women with prediabetes.

Key data points:

• Martens et al. 2023 (Nature Aging) studied NR at 1,000 mg/day in older adults (mean age 71, mixed sex) for 21 days and found increased whole-blood NAD+ but no significant change in cardiometabolic markers. Sex-stratified data were not published separately.

• A 2022 systematic review in Nutrients covering 8 NMN/NR trials concluded that NAD+ precursors reliably raise blood NAD+ levels but that clinical endpoints (insulin sensitivity, cognitive function, physical performance) showed inconsistent results across trials, with most trials underpowered to detect modest effects.

• NAMS (The Menopause Society) has not issued a position statement endorsing NAD+ precursors for menopausal symptom management as of 2026.

The honest clinical picture: NAD+ precursors reliably raise NAD+ levels in blood. Whether that translates to meaningful clinical benefit in women across life stages requires larger, longer, sex-stratified trials. The candidacy for LMN documentation exists for women with documented metabolic conditions, but general wellness use should be weighed against the monthly cost and the current evidence ceiling.

Practical Steps to Take This Week

1. Pull your benefits summary from HR or your employer benefits portal. Look for HSA, FSA, LSA, wellness stipend, and ICHRA sections.
2. Call your FSA/HSA administrator and ask directly: "Will you reimburse a dietary supplement for a diagnosed condition with a Letter of Medical Necessity?"
3. Book a telehealth visit with a WomanRx clinician to discuss whether your health history supports an LMN for NMN or NR.
4. If your ICHRA platform is PeopleKeep, Take Command, or Thatch, log in and search "supplements" in the expense eligibility tool before submitting.
5. Start at 250 mg/day if you and your clinician agree to proceed. The Yoshino trial used this dose and produced measurable NAD+ effects in postmenopausal women with prediabetes. This dose costs roughly half what a 500 mg/day regimen costs monthly.

Your FSA grace period or plan-year deadline may affect timing. Check your FSA plan year end date before submitting LMN claims.